Last edition
News about "cancer cells"
Boehringer Ingelheim, SBP Group Sign USD 7.36 Billion Oncology Deal
Boehringer Ingelheim and China's SBP Group have entered into a multi-programme oncology agreement covering six pre-clinical programmes based on ADC and T-cell engager technologies, with potential milestone payments of up to USD 7 billion.
Cancer Cells | 05/11/2026 | By News Bureau | 103
Japan’s health ministry approves the first in world combination of Lunsumio and Polivy, showing strong response rates and reduced disease progression risk in relapsed or refractory lymphoma patients.
Cancer Cells | 24/03/2026 | By News Bureau | 201
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy